
Christopher Sweeney, MBBS
@chrissweens1
Cancer Researcher & Oncologist Prior @DanaFarber, Prof of Med @Harvardmed. Member @Uromigos. Dec 2022 Director @SAiGENCI and Prof at Uni of Adelaide. Views mine
ID: 3279005954
14-07-2015 00:15:25
982 Tweet
4,4K Followers
298 Following

Congratulating South Australian immunoGENomics Cancer Institute legends Lisa Butler and Mohamed I. Saad on their NHMRC Ideas Grant success! See project details at adelaide.edu.au/newsroom/news/… Uni of Adelaide 👏👊🎉


In memory of Dr. Felix Feng. Thank you European Urology for honoring our beloved colleague and friend, gone too soon. We miss you Felix Mary Feng Nancy Lin, MD PCF Science sciencedirect.com/science/articl…


Our latest #ICECAP work looking at whether clinical risk can identify benefit from short v long-term ADT in high-risk prostate cancer, published in Prostate Cancer and Prostatic Diseases: rdcu.be/d5C8H Christopher Sweeney, MBBS Wanling tombal silke gillessen Daniel E Spratt Paul Nguyen


South Australian immunoGENomics Cancer Institute are grateful for the support of Australia's Economic Accelerator in developing SAi001, offering critical protection from immediate and lasting impacts of radiation. Read more at srkr.io/6042XQA Ab Initio Pharma DMTC Ltd Axiom Space Defence Innovation Partnership Uni of Adelaide

Great to welcome South Australian immunoGENomics Cancer Institute's 2024-25 Summer Research Students at morning tea today. These undergraduate students are working with our researchers gaining valuable research experience and an insight into a career in science. Uni of Adelaide Adelaide Centre for Epigenetics 🧪🔬


The mechanism underlying the progression of castration-resistant prostate cancer! This month’s cover features work by Katherine Morel Beatriz Christopher Sweeney, MBBS ExpressionEngine & team showing Tristetraprolin regulates phenotypic plasticity of prostate cancer: jci.org/articles/view/…


Latest journey in #prostatecancer cell plasticity. Team effort Christopher Sweeney, MBBS Katherine Morel Beatriz Work stems from previous Christopher Sweeney, MBBS investigations in NFkB regulation by tristetraprolin (TTP; gene ZFP36), and generation of the NFkBi dimethylaminoparthenolide (DMAPT)


Pluvicto now w/ expanded FDA Oncology approval based off #PSMAfore: progressive mCRPC Pluvicto Vs ARPI - rPFS 9.3 Vs 5.6mos (HR: 0.41) - ARPI ⛔️ ideal on progression after upfront ARPI. Cost & Access to keep in mind. - Summary Christopher Sweeney, MBBS from ESMO - Eur. Oncology #OncTwitter #gusm


👏Thrilled to announce South Australian immunoGENomics Cancer Institute's Dr. Yannan Yang awarded in the latest round of MRFF EMCR funding for his research into brain cancer. Read more at adelaide.edu.au/newsroom/news/… Congratulations Yannan! Uni of Adelaide 🧪🔬👊


Great to see a full-house for South Australian immunoGENomics Cancer Institute's third Annual Public Lecture on Tuesday night featuring Jenkins Lab and Dr. Mara Zeissig speaking on the topic of "Fighting cancer from within: your immune system may hold the key" youtube.com/watch?v=z2KcRI… Uni of Adelaide


🚨 New episode alert! silke gillessen and Christopher Sweeney, MBBS join us to discuss our latest 'Uromigos Score' in which experts score the value of treatments for advanced prostate cancer. Expect some interesting themes and insights. 🎙️ GU Oncology Now: buff.ly/GzQAw1J 🍎





Great to see @ANZUPTrials #ENZAMET 8-year outcomes poster at #ASCO25 presented by Alison Zhang Christopher Sweeney, MBBS Ian Davis (Bluesky @profiand) NHMRC CTC CancerTrialsIreland 🌈 CCTG Astellas Pharma US #CancerAustralia



Online: Metformin for patients with metastatic #prostatecancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol silke gillessen, Nick James also on @Prof-Nick-James.bsky.social, Ashwin Sachdeva, and colleagues thelancet.com/journals/lanon…
